Mathieu C - Search Results

1

Vitamin D and diabetes.

Mathieu C, Gysemans C, Giulietti A, Bouillon R. Mathieu C, et al. Diabetologia. 2005 Jul;48(7):1247-57. doi: 10.1007/s00125-005-1802-7. Epub 2005 Jun 22. Diabetologia. 2005. PMID: 15971062 Review.

2

1,25-Dihydroxyvitamin D3 prevents insulitis in NOD mice.

Mathieu C, Laureys J, Sobis H, Vandeputte M, Waer M, Bouillon R. Mathieu C, et al. Diabetes. 1992 Nov;41(11):1491-5. doi: 10.2337/diab.41.11.1491. Diabetes. 1992. PMID: 1397723

3

Potential role of 1,25(OH)2 vitamin D3 as a dose-reducing agent for cyclosporine and FK 506.

Mathieu C, Bouillon R, Rutgeerts O, Vandeputte M, Waer M. Mathieu C, et al. Transplant Proc. 1994 Dec;26(6):3130. Transplant Proc. 1994. PMID: 7527950 No abstract available.

4

Immunomodulatory effects of 1,25-dihydroxyvitamin D3.

Casteels K, Bouillon R, Waer M, Mathieu C. Casteels K, et al. Among authors: mathieu c. Curr Opin Nephrol Hypertens. 1995 Jul;4(4):313-8. doi: 10.1097/00041552-199507000-00005. Curr Opin Nephrol Hypertens. 1995. PMID: 7552096 Review.

5

Paracrine role for calcitriol in the immune system and skin creates new therapeutic possibilities for vitamin D analogs.

Bouillon R, Garmyn M, Verstuyf A, Segaert S, Casteels K, Mathieu C. Bouillon R, et al. Among authors: mathieu c. Eur J Endocrinol. 1995 Jul;133(1):7-16. doi: 10.1530/eje.0.1330007. Eur J Endocrinol. 1995. PMID: 7627339 Review. No abstract available.

6

Non-hypercalcemic pharmacological aspects of vitamin D analogs.

Bouillon R, Verstuyf A, Verlinden L, Allewaert K, Branisteanu D, Mathieu C, van Baelen H. Bouillon R, et al. Among authors: mathieu c. Biochem Pharmacol. 1995 Aug 25;50(5):577-83. doi: 10.1016/0006-2952(95)00121-f. Biochem Pharmacol. 1995. PMID: 7669059 Review. No abstract available.

7

Prevention of type I diabetes in NOD mice by nonhypercalcemic doses of a new structural analog of 1,25-dihydroxyvitamin D3, KH1060.

Mathieu C, Waer M, Casteels K, Laureys J, Bouillon R. Mathieu C, et al. Endocrinology. 1995 Mar;136(3):866-72. doi: 10.1210/endo.136.3.7867594. Endocrinology. 1995. PMID: 7867594

8

Induction of mixed bone marrow chimerism as potential therapy for autoimmune (type I) diabetes: experience in the NOD model.

Mathieu C, Bouillon R, Rutgeerts O, Waer M. Mathieu C, et al. Transplant Proc. 1995 Feb;27(1):640-1. Transplant Proc. 1995. PMID: 7879129 No abstract available.

9

Prevention of autoimmune diabetes in NOD mice by 1,25 dihydroxyvitamin D3.

Mathieu C, Waer M, Laureys J, Rutgeerts O, Bouillon R. Mathieu C, et al. Diabetologia. 1994 Jun;37(6):552-8. doi: 10.1007/BF00403372. Diabetologia. 1994. PMID: 7926338

10

Activated form of vitamin D [1,25(OH)2D3] and its analogs are dose-reducing agents for cyclosporine in vitro and in vivo.

Mathieu C, Waer M, Laureys J, Rutgeerts O, Bouillon R. Mathieu C, et al. Transplant Proc. 1994 Oct;26(5):3048-9. Transplant Proc. 1994. PMID: 7940957 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results